Zoom Logo

RADx Webinar Series - Shared screen with speaker view
Tracy McMahon
33:16
poctrn.org
Miss Janice Velasco Layugan
33:50
Hi Everyone!
Snyder, Mark
34:19
www.covidtests.gov is live
Venkatesan Renugopalakrishnan
38:38
Very recently the presence of both Delta and Omicron in the same patient has surfaced. Any comments ? Renu
Steven Schachter
55:18
Cambridge, Massachusetts
Vivian Jonas-Taggart
59:26
Saliva is not the best sample type for detecting SARS-CoV-2. This raises questions about the study.
Dilip Kumar Agarwal
01:05:51
Why the Omicron is highly contagious but less lethal? Is it because of antibody cocktail in the form of vaccination we have been administered over the period of time? Or high mutation rate changing virus structure from its predecessor inhibiting more viral load binding to ACE2 receptor and so less infection?
Miss Janice Velasco Layugan
01:20:02
Thanks so much for the extremely educating presentation, superb!
Juan de la Torre
01:20:10
Most of the immunity assessment is based on antibody responses. What we know about T cell responses that could provide long-term protection against disease symptoms, despite not being able to provide protection against infection.
Leticia Cruz
01:24:15
what differences have you seen in disease development within the lungs parynchima with original covid and omicron and what are the risks for long covid . If you are contaminated with omicron can you still suffer from long covid .
Miss Janice Velasco Layugan
01:28:56
If the testings are not that reliable, then vaccination should be implemented, regardless?
Leticia Cruz
01:30:59
I am concerned wioth the lasting effects upon the lungs parynchima with comparison between covid 191 and omicron . will I have to perform interventions in occupational health ?
Leticia Cruz
01:31:23
I am talking about my US workforce.
Tracy McMahon
01:31:45
This will be available on poctrn.org
Shari Thompson
01:31:54
Thank you. This was really informative!!
Gene Millar
01:32:11
Outstanding, Bill. Thanks and best wishes!
Miss Janice Velasco Layugan
01:32:12
Once more, thanks so much.
Dilip Kumar Agarwal
01:32:27
Great talk
Q280_US2
01:32:53
Thank you so much for presentation.
Lucy Galindo
01:32:55
Thank you!